Yohimbine

    Researchedby:
    Brady Holmer

    Fact-checked

    by:

    Gregory Lopez
    Last Updated: October 13, 2024

    Yohimbine is promoted for its fat-burning properties and benefits for male sexual dysfunction. Though yohimbine is effective, side effects may include anxiety, nervousness, and an elevated heart rate, and the reported dose of yohimbine in many supplement formulas doesn’t match the actual dose.

    What is yohimbine?

    Yohimbine is a naturally occurring alkaloid found in the Pausinystalia yohimbe tree and the Rauwolfia serpentina plant. Yohimbine is a stimulatory compound that primarily acts on the alpha-2-adrenergic receptors in the body.[1] It’s best known for its ability to increase fat burning (lipolysis)[2] and aid in male sexual dysfunction.[3] Yohimbine supplementation is also used for weight loss,[4][5][6] body composition,[7][6] treatment of phobias,[8][9] and orthostatic hypotension,[10] though there is a lack of evidence to support yohimbine’s benefits for many of these conditions.

    What are yohimbine’s main benefits?

    Some evidence supports the use of yohimbine as a natural way to improve symptoms of erectile dysfunction (ED) in men. While studies have questioned this claim,[11] two meta-analyses concluded that yohimbine taken alone[12] or alongside other therapies, including arginine and PDE-5 inhibitors,[13] improves ED when compared to a placebo, though studies using combined yohimbine and PDE-5 inhibitors have only been conducted in animals.[14]

    Although it’s often marketed as a fat-loss and performance-enhancing supplement for athletes, there’s no evidence that yohimbine improves strength, increases muscle, or enhances physical performance.[15] Yohimbine does seem to have a lipolytic effect (increases “fat burning”)[15] and may improve body composition[6] or cause regional fat loss when used as a topical ointment.[7]

    What are yohimbine’s main drawbacks?

    When taken at the recommended dose (≤0.2 mg per kg of body weight), yohimbine may cause nausea, abdominal pain, dizziness, nervousness, and anxiety.[16]

    Higher doses of yohimbine may be dangerous; a report from 2005 found that yohimbine had the highest rate of toxic effects of any botanical product.[17] Case reports of excess yohimbine ingestion have suggested that anxiety, hypertension (high blood pressure), tachycardia (high heart rate), arrhythmias, and agitation are among the more severe side effects of this compound.[15]

    Furthermore, many yohimbine-containing supplements in the U.S. were found to be inaccurately labeled — they contained 23%–147% of the yohimbine reported on the label and failed to report the amount of yohimbine contained in the product or warn of the potential harms of excess consumption.[18]

    How does yohimbine work?

    Yohimbine is a selective alpha-2-adrenergic antagonist. In other words, it targets and inactivates a class of receptors in the nervous system that is responsive to the neurotransmitter norepinephrine (noradrenaline).[19] Alpha-2 receptor antagonism enhances the sympathetic nervous system release of norepinephrine, causing the stimulatory and “hyperadrenergic” effects of yohimbine.

    Antagonism of alpha-2 receptors also inhibits penile smooth muscle contraction and may enhance nitric oxide-mediated smooth muscle relaxation — the combined effects of which promote erection and explain the improvement in ED symptoms after supplementing with yohimbine.[20] Yohimbine also inhibits the activity of alpha-2 receptors on fat cells — where norepinephrine normally acts to suppress fat release. Inhibition of the antilipolytic effect of norepinephrine allows more lipolysis (fat burning) to occur.[2]

    What are other names for Yohimbine

    Note that Yohimbine is also known as:
    • Yohimbe
    • Corynanthe Yohimbe
    • Yohimbe Bark
    • Pausinystalia Yohimbe

    Dosage information

    Total daily dosages of 0.2mg/kg bodyweight have been successfully used to increase fat burning without significant implications on cardiovascular parameters like heart rate and blood pressure. This results in a total daily dosage of:

    • 14 mg for a 150 lb (68 kg) person
    • 18 mg for a 200 lb (91 kg) person
    • 22 mg for a 250 lb (113 kg) person

    These total daily doses are often divided and taken in two to four doses throughout the day. For example, a 150 lb (68 kg) person could take 7 mg twice daily to reach to total dose of 14 mg.

    Supplementation is most effective between meals or during short term fasting.

    Caution should be exercised at higher body weight, since the cardiovascular system may not be prepared to handle a stimulatory agent such as yohimbine. When supplementing yohimbine for the first time, always start with a half-dose and assess tolerance before proceeding.

    Caution should also be exercised since many supplements containing yohimbine either do not list how much yohimbine is included, or if they do, the actual dose ranges from 25-150% of the dose listed. Since the dosage may be higher than listed, this is extra reason to start with a lower dose.

    When pairing yohimbine with other stimulatory agents, half-dose both supplements and work up to the recommended dose cautiously, as two supplements can interact negatively.

    Frequently asked questions

    What is yohimbine?

    Yohimbine is a naturally occurring alkaloid found in the Pausinystalia yohimbe tree and the Rauwolfia serpentina plant. Yohimbine is a stimulatory compound that primarily acts on the alpha-2-adrenergic receptors in the body.[1] It’s best known for its ability to increase fat burning (lipolysis)[2] and aid in male sexual dysfunction.[3] Yohimbine supplementation is also used for weight loss,[4][5][6] body composition,[7][6] treatment of phobias,[8][9] and orthostatic hypotension,[10] though there is a lack of evidence to support yohimbine’s benefits for many of these conditions.

    What are yohimbine’s main benefits?

    Some evidence supports the use of yohimbine as a natural way to improve symptoms of erectile dysfunction (ED) in men. While studies have questioned this claim,[11] two meta-analyses concluded that yohimbine taken alone[12] or alongside other therapies, including arginine and PDE-5 inhibitors,[13] improves ED when compared to a placebo, though studies using combined yohimbine and PDE-5 inhibitors have only been conducted in animals.[14]

    Although it’s often marketed as a fat-loss and performance-enhancing supplement for athletes, there’s no evidence that yohimbine improves strength, increases muscle, or enhances physical performance.[15] Yohimbine does seem to have a lipolytic effect (increases “fat burning”)[15] and may improve body composition[6] or cause regional fat loss when used as a topical ointment.[7]

    What are yohimbine’s main drawbacks?

    When taken at the recommended dose (≤0.2 mg per kg of body weight), yohimbine may cause nausea, abdominal pain, dizziness, nervousness, and anxiety.[16]

    Higher doses of yohimbine may be dangerous; a report from 2005 found that yohimbine had the highest rate of toxic effects of any botanical product.[17] Case reports of excess yohimbine ingestion have suggested that anxiety, hypertension (high blood pressure), tachycardia (high heart rate), arrhythmias, and agitation are among the more severe side effects of this compound.[15]

    Furthermore, many yohimbine-containing supplements in the U.S. were found to be inaccurately labeled — they contained 23%–147% of the yohimbine reported on the label and failed to report the amount of yohimbine contained in the product or warn of the potential harms of excess consumption.[18]

    How does yohimbine work?

    Yohimbine is a selective alpha-2-adrenergic antagonist. In other words, it targets and inactivates a class of receptors in the nervous system that is responsive to the neurotransmitter norepinephrine (noradrenaline).[19] Alpha-2 receptor antagonism enhances the sympathetic nervous system release of norepinephrine, causing the stimulatory and “hyperadrenergic” effects of yohimbine.

    Antagonism of alpha-2 receptors also inhibits penile smooth muscle contraction and may enhance nitric oxide-mediated smooth muscle relaxation — the combined effects of which promote erection and explain the improvement in ED symptoms after supplementing with yohimbine.[20] Yohimbine also inhibits the activity of alpha-2 receptors on fat cells — where norepinephrine normally acts to suppress fat release. Inhibition of the antilipolytic effect of norepinephrine allows more lipolysis (fat burning) to occur.[2]

    Research Breakdown

    References

    1. ^Hedner T, Edgar B, Edvinsson L, Hedner J, Persson B, Pettersson AYohimbine pharmacokinetics and interaction with the sympathetic nervous system in normal volunteers.Eur J Clin Pharmacol.(1992)
    2. ^Lafontan M, Berlan M, Galitzky J, Montastruc JLAlpha-2 adrenoceptors in lipolysis: alpha 2 antagonists and lipid-mobilizing strategies.Am J Clin Nutr.(1992-01)
    3. ^Tam SW, Worcel M, Wyllie MYohimbine: a clinical review.Pharmacol Ther.(2001-Sep)
    4. ^Jonderko K, Kucio CEffect of anti-obesity drugs promoting energy expenditure, yohimbine and ephedrine, on gastric emptying in obese patientsAliment Pharmacol Ther.(1991 Aug)
    5. ^Kucio C, Jonderko K, Piskorska DDoes yohimbine act as a slimming drug?Isr J Med Sci.(1991-Oct)
    6. ^Ostojic SMYohimbine: the effects on body composition and exercise performance in soccer playersRes Sports Med.(2006 Oct-Dec)
    7. ^F L Greenway, G A BrayRegional fat loss from the thigh in obese women after adrenergic modulationClin Ther.(1987)
    8. ^Powers MB, Smits JA, Otto MW, Sanders C, Emmelkamp PMFacilitation of fear extinction in phobic participants with a novel cognitive enhancer: a randomized placebo controlled trial of yohimbine augmentationJ Anxiety Disord.(2009 Apr)
    9. ^Meyerbroeker K, Powers MB, van Stegeren A, Emmelkamp PMDoes yohimbine hydrochloride facilitate fear extinction in virtual reality treatment of fear of flying? A randomized placebo-controlled trialPsychother Psychosom.(2012)
    10. ^Shibao C, Okamoto LE, Gamboa A, Yu C, Diedrich A, Raj SR, Robertson D, Biaggioni IComparative efficacy of yohimbine against pyridostigmine for the treatment of orthostatic hypotension in autonomic failureHypertension.(2010 Nov)
    11. ^Shamloul RNatural aphrodisiacs.J Sex Med.(2010-Jan)
    12. ^Ernst E, Pittler MHYohimbine for erectile dysfunction: a systematic review and meta-analysis of randomized clinical trialsJ Urol.(1998 Feb)
    13. ^Wibowo DNSA, Soebadi DM, Soebadi MAYohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis.Turk J Urol.(2021-Nov)
    14. ^Senbel AM, Mostafa TYohimbine enhances the effect of sildenafil on erectile process in rats.Int J Impot Res.(2008)
    15. ^Cimolai N, Cimolai TYohimbine use for physical enhancement and its potential toxicity.J Diet Suppl.(2011-Dec)
    16. ^Kearney T, Tu N, Haller CAdverse drug events associated with yohimbine-containing products: a retrospective review of the California Poison Control System reported cases.Ann Pharmacother.(2010-Jun)
    17. ^Woolf AD, Watson WA, Smolinske S, Litovitz TThe severity of toxic reactions to ephedra: comparisons to other botanical products and national trends from 1993-2002.Clin Toxicol (Phila).(2005)
    18. ^Cohen PA, Wang YH, Maller G, DeSouza R, Khan IAPharmaceutical quantities of yohimbine found in dietary supplements in the USA.Drug Test Anal.(2016)
    19. ^Murburg MM, Villacres EC, Ko GN, Veith RCEffects of yohimbine on human sympathetic nervous system function.J Clin Endocrinol Metab.(1991-Oct)
    20. ^Guay AT, Spark RF, Jacobson J, Murray FT, Geisser MEYohimbine treatment of organic erectile dysfunction in a dose-escalation trialInt J Impot Res.(2002 Feb)
    21. ^Rodriguez-Castro CE, Saifuddin F, Porres-Aguilar M, Said S, Gough D, Siddiqui T, Mukherjee D, Abbas AReverse takotsubo cardiomyopathy with use of male enhancers.Proc (Bayl Univ Med Cent).(2015 Jan)
    22. ^N R Musso, C Vergassola, A Pende, G LottiYohimbine effects on blood pressure and plasma catecholamines in human hypertensionAm J Hypertens.(1995 Jun)
    23. ^Charney DS, Woods SW, Goodman WK, Heninger GRNeurobiological mechanisms of panic anxiety: biochemical and behavioral correlates of yohimbine-induced panic attacks.Am J Psychiatry.(1987 Aug)
    24. ^D S Charney, G R Heninger, A BreierNoradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorderArch Gen Psychiatry.(1984 Aug)
    25. ^HOLMBERG G, GERSHON SAutonomic and psychic effects of yohimbine hydrochloride.Psychopharmacologia.(1961)
    26. ^Vay M, Meyer MJ, Blank A, Skopp G, Rose P, Tzvetkov MV, Mikus GOral Yohimbine as a New Probe Drug to Predict CYP2D6 Activity: Results of a Fixed-Sequence Phase I Trial.Clin Pharmacokinet.(2020 Jul)
    27. ^Stoll F, Blank A, Mikus G, Czock D, Weiss J, Meyer-Tönnies MJ, Gümüs KS, Tzvetkov M, Burhenne J, Haefeli WEEvaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers.Eur J Drug Metab Pharmacokinet.(2024 Jan)
    28. ^Mueller-Schoell A, Michelet R, Weinelt F, Kloft C, Mikus GCYP2D6 phenotype explains reported yohimbine concentrations in four severe acute intoxications.Arch Toxicol.(2021 Aug)
    29. ^Waluga M, Janusz M, Karpel E, Hartleb M, Nowak ACardiovascular effects of ephedrine, caffeine and yohimbine measured by thoracic electrical bioimpedance in obese women.Clin Physiol.(1998 Jan)
    30. ^Vay, M. et alSimultaneous quantification of the CYP2D6 substrate yohimbine, its metabolite 11-OH-yohimbine, and the CYP2D6 inhibitor paroxetine in human plasmaAnal Methods.(November 4, 2019)
    31. ^A E Bharucha, T Skaar, C N Andrews, M Camilleri, S Philips, B Seide, D Burton, K Baxter, A R ZinsmeisterRelationship of cytochrome P450 pharmacogenetics to the effects of yohimbine on gastrointestinal transit and catecholamines in healthy subjectsNeurogastroenterol Motil.(2008 Aug)
    32. ^Pascal Le Corre, Robert J Parmer, Mala T Kailasam, Brian P Kennedy, Todd P Skaar, Herbert Ho, Roger Leverge, Douglas W Smith, Michael G Ziegler, Paul A Insel, Nicholas J Schork, David A Flockhart, Daniel T O'connorHuman sympathetic activation by alpha2-adrenergic blockade with yohimbine: Bimodal, epistatic influence of cytochrome P450-mediated drug metabolismClin Pharmacol Ther.(2004 Aug)
    33. ^Haron MH, Dale O, Martin K, Avula B, Chittiboyina AG, Khan IA, Gurley BJ, Khan SIEvaluation of the Herb-Drug Interaction Potential of Commonly Used Botanicals on the US Market with Regard to PXR- and AhR-Mediated Influences on CYP3A4 and CYP1A2.J Diet Suppl.(2023)
    34. ^D S Charney, A Breier, P I Jatlow, G R HeningerBehavioral, biochemical, and blood pressure responses to alprazolam in healthy subjects: interactions with yohimbinePsychopharmacology (Berl).(1986)
    35. ^Mattila M, Seppala T, Mattila MJAnxiogenic effect of yohimbine in healthy subjects: comparison with caffeine and antagonism by clonidine and diazepam.Int Clin Psychopharmacol.(1988 Jul)
    36. ^M Albus, T P Zahn, A BreierAnxiogenic properties of yohimbine. II. Influence of experimental set and settingEur Arch Psychiatry Clin Neurosci.(1992)
    37. ^Charney DS, Heninger GR, Redmond DEYohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine.Life Sci.(1983-Jul-04)
    38. ^Anderson C, Anderson D, Harre N, Wade NCase study: two fatal case reports of acute yohimbine intoxication.J Anal Toxicol.(2013-Oct)
    39. ^Andrea Giampreti, Davide Lonati, Carlo Locatelli, Loretta Rocchi, Maria Teresa CampaillaAcute neurotoxicity after yohimbine ingestion by a body builderClin Toxicol (Phila).(2009 Sep)
    40. ^Dunn, R. et alYohimbine-induced seizures in mice: A model predictive of potential anxiolytic and GABA-mimetic agentsDrug Dev Res.(1987)
    41. ^Riley, A. et alDouble Blind Trial of Yohimbine Hydrochloride in the Treatment of Erection InadequacySex Relat Ther.(October 27, 2010)
    42. ^Roberge RJ, Kimball ET, Rossi J, Warren JClonidine and sleep apnea syndrome interaction: antagonism with yohimbine.J Emerg Med.(1998 Sep-Oct)
    43. ^Jain NK, Kulkarni SK, Singh AModulation of NSAID-induced antinociceptive and anti-inflammatory effects by alpha2-adrenoceptor agonists with gastroprotective effects.Life Sci.(2002 May 3)
    44. ^Bagheri H, Picault P, Schmitt L, Houin G, Berlan M, Montastruc JLPharmacokinetic study of yohimbine and its pharmacodynamic effects on salivary secretion in patients treated with tricyclic antidepressants.Br J Clin Pharmacol.(1994 Jan)
    45. ^L Lacomblez, G Bensimon, F Isnard, B Diquet, Y Lecrubier, A J PuechEffect of yohimbine on blood pressure in patients with depression and orthostatic hypotension induced by clomipramineClin Pharmacol Ther.(1989 Mar)
    46. ^Lecrubier Y, Puech AJ, Des Lauriers AFavourable effects of yohimbine on clomipramine-induced orthostatic hypotension: a double-blind study.Br J Clin Pharmacol.(1981 Jul)
    47. ^I P LapinAdrenergic nonspecific potentiation of yohimbine toxicity in mice by antidepressants and related drugs and antiyohimbine action of antiadrenergic and serotonergic drugsPsychopharmacology (Berl).(1980)
    48. ^Silva LC, Miranda e Castor MG, Souza TC, Duarte ID, Romero TRNSAIDs induce peripheral antinociception by interaction with the adrenergic system.Life Sci.(2015 Jun 1)
    49. ^Pinardi G, Sierralta F, Miranda HFAdrenergic mechanisms in antinociceptive effects of non steroidal anti-inflammatory drugs in acute thermal nociception in mice.Inflamm Res.(2002 May)
    50. ^Prabir Lahiri, Utpal Chaudhuri, Anjan Kr Dasgupta, S N Ray, S Saha, P MukherjeeInsensitivity to the alpha2-adrenergic receptor blocker yohimbine hydrochloride and occurrence of spontaneous platelet macroaggregation (SPMA) in diabetesPlatelets.(2005 Mar)
    51. ^Lahiri P, Roy S, Sardar P, Deb S, Chakrabarti P, Guha P, Guha S, Chaudhuri U, Dasgupta AKPlatelet responsiveness to yohimbine hydrochloride and MRS2179 in the context of the interaction between collagen and epinephrine in acute coronary syndrome.Blood Cells Mol Dis.(2009 Jul-Aug)
    52. ^Andrews NP, Goldstein DS, Quyyumi AAEffect of systemic alpha-2 adrenergic blockade on the morning increase in platelet aggregation in normal subjects.Am J Cardiol.(1999 Aug 1)
    53. ^Berlin I, Crespo-Laumonnier B, Cournot A, Landault C, Aubin F, Legrand JC, Puech AJThe alpha 2-adrenergic receptor antagonist yohimbine inhibits epinephrine-induced platelet aggregation in healthy subjects.Clin Pharmacol Ther.(1991 Apr)
    54. ^Goldberg MR, Hollister AS, Robertson DInfluence of yohimbine on blood pressure, autonomic reflexes, and plasma catecholamines in humans.Hypertension.(1983 Sep-Oct)
    55. ^Galitzky J, Rivière D, Tran MA, Montastruc JL, Berlan MPharmacodynamic effects of chronic yohimbine treatment in healthy volunteers.Eur J Clin Pharmacol.(1990)
    56. ^Raman V, Avula B, Galal AM, Wang YH, Khan IAMicroscopic and UPLC-UV-MS analyses of authentic and commercial yohimbe (Pausinystalia johimbe) bark samples.J Nat Med.(2013 Jan)
    57. ^Sun J, Chen PChromatographic fingerprint analysis of yohimbe bark and related dietary supplements using UHPLC/UV/MS.J Pharm Biomed Anal.(2012 Mar 5)
    58. ^Zanolari B, Ndjoko K, Ioset JR, Marston A, Hostettmann KQualitative and quantitative determination of yohimbine in authentic yohimbe bark and in commercial aphrodisiacs by HPLC-UV-API/ MS methods.Phytochem Anal.(2003 Jul-Aug)
    59. ^Betz JM, White KD, der Marderosian AHGas chromatographic determination of yohimbine in commercial yohimbe products.J AOAC Int.(1995 Sep-Oct)
    60. ^Lucas D, Neal-Kababick J, Zweigenbaum JCharacterization and quantitation of yohimbine and its analogs in botanicals and dietary supplements using LC/QTOF-MS and LC/QQQ-MS for determination of the presence of bark extract and yohimbine adulteration.J AOAC Int.(2015 Mar-Apr)
    61. ^Li W, Wertheimer ANarrative Review: The FDA's Perfunctory Approach of Dietary Supplement Regulations Giving Rise to Copious Reports of Adverse Events.Innov Pharm.(2023)
    62. ^Palladino A, Butcher RL, Fugo NWAn additional effect of yohimbine-HCl.Proc Soc Exp Biol Med.(1968 Feb)
    63. ^S VarkeyOverdose of yohimbineBMJ.(1992 Feb 29)
    64. ^Ruck B, Shih RD, Marcus SMHypertensive crisis from herbal treatment of impotence.Am J Emerg Med.(1999 May)
    65. ^Sandler B, Aronson PYohimbine-induced cutaneous drug eruption, progressive renal failure, and lupus-like syndrome.Urology.(1993-Apr)
    66. ^Linden CH, Vellman WP, Rumack BYohimbine: a new street drug.Ann Emerg Med.(1985 Oct)
    67. ^Myers A, Barrueto F JrRefractory priapism associated with ingestion of yohimbe extract.J Med Toxicol.(2009 Dec)
    68. ^Landis E, Shore EYohimbine-induced bronchospasm.Chest.(1989 Dec)
    69. ^Siddiqui MA, More-O'Ferrall D, Hammod RS, Baime RV, Staddon APAgranulocytosis associated with yohimbine use.Arch Intern Med.(1996 Jun 10)
    70. ^K R WylieYohimbine and sinusitisBr J Psychiatry.(1996 Sep)
    71. ^Drevin, G. et alA fatal case report of acute yohimbine intoxicationForensic Toxicol.(December 6, 2019)
    72. ^Zhu L, Han X, Zhu J, Du L, Liu L, Gong WSevere acute intoxication with yohimbine: Four simultaneous poisoning cases.Forensic Sci Int.(2021 Mar)